Proteinase-3 as an autoantigen and the development of granulomatosis with polyangiitis
Main Article Content
Keywords
human proteinase 3, autoantibody, vasculitis, autoimmune, ANCA, immune
Abstract
Human proteinase 3 (hPR3) is a lysosomal enzyme of the serine protease type. In autoimmune vasculitis, autoantibodies to hPR3 appear to have a role in the inception of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), where this protein is the main autoantigen. Indeed, patients with antibodies against hPR3 have more severe symptoms, relapses, and resistance to immunosuppressive therapies, supporting an important role for this autoantigen in the pathophysiology and severity of AAV. In this review, we describe what is known about the role of hPR3 in pathophysiology, diagnosis of AAV, and some perspectives on its treatment.
References
1 Bosch X, Guilabert A, Font J. Antineutrophil cytoplasmic antibodies. The Lancet. 2006;368(9533):404–18. 10.1016/S0140-6736(06)69114-9
2 Crisford H, Sapey E, Stockley RA. Proteinase 3: A potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases. Respir Res. 2018;19(1):180. 10.1186/s12931-018-0883-z
3 Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5):603–6. 10.1007/s10157-013-0869-6
4 Bossuyt X, Cohen Tervaert JW, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin L, et al. Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol. 2017;13(11):683–92. 10.1038/nrrheum.2017.140
5 Arnold S, Kitching AR, Witko-Sarsat V, Wiech T, Specks U, Klapa S, et al. Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis. Lancet Rheumatol. 2024;6(5):e300–13. 10.1016/S2665-9913(24)00025-0
6 Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337(21):1512–23. 10.1056/NEJM199711203372106
7 Kettritz R. How anti-neutrophil cytoplasmic autoantibodies activate neutrophils. Clin Exp Immunol. 2012;169(3):220–8. 10.1111/j.1365-2249.2012.04615.x
8 Jennette JC, Falk RJ. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol. 2014;10(8):463–73. 10.1038/nrrheum.2014.103
9 Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11. 10.1002/art.37715
10 Choi CB, Park YB, Lee SW. Antineutrophil cytoplasmic antibody-associated vasculitis in Korea: A Narrative Review. Yonsei Med J. 2019;60(1):10–21. 10.3349/ymj.2019.60.1.10
11 Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187–92. 10.1002/art.1780370206
12 Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66(2):222–7. 10.1136/ard.2006.054593
13 Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;6(1):1–27. 10.1038/s41572-020-0204-y
14 Falde SD, Fussner LA, Tazelaar HD, O’Brien EK, Lamprecht P, Konig MF, et al. Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis. Lancet Rheumatol. 2024;6(5):e314–27. 10.1016/S2665-9913(24)00035-3
15 Cabral DA, Uribe AG, Benseler S, O’Neil KM, Hashkes PJ, Higgins G, et al. Classification, presentation, and initial treatment of Wegener’s granulomatosis in childhood. Arthritis Rheum. 2009;60(11):3413–24. 10.1002/art.24876
16 Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DRW, Scott DGI, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK. Rheumatology. 2011;50(10):1916–20. 10.1093/rheumatology/ker205
17 Wu CS, Hsieh CJ, Peng YS, Chang TH, Wu ZY. Antineutrophil cytoplasmic antibody-associated vasculitis in Taiwan: A hospital-based study with reference to the population-based National Health Insurance database. J Microbiol Immunol Infect. 2015;48(5):477–82. 10.1016/j.jmii.2013.12.006
18 Lamprecht P, Kerstein A, Klapa S, Schinke S, Karsten CM, Yu X, et al. Pathogenetic and clinical aspects of anti-neutrophil cytoplasmic autoantibody-associated vasculitides. Frontiers in immunology [Internet]. 2018 Sep 4 [cited 2023 Jul 24]; 9. Available from: https://pubmed.ncbi.nlm.nih.gov/29686675/
19 Berti A, Cornec D, Crowson CS, Specks U, Matteson EL. The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in Olmsted County, Minnesota: A twenty-year US population-based study. Arthritis Rheumatol. 2017;69(12):2338–50. 10.1002/art.40313
20 Ntatsaki E, Watts RA, Scott DGI. Epidemiology of ANCA-associated vasculitis. Rheum Dis Clin North Am. 2010;36(3):447–61. 10.1016/j.rdc.2010.04.002
21 Panupattanapong S, Stwalley DL, White AJ, Olsen MA, French AR, Hartman ME. Epidemiology and outcomes of granulomatosis With polyangiitis in pediatric and working-age adult populations in the United States: Analysis of a large national claims database. Arthritis Rheumatol. 2018;70(12):2067–76. 10.1002/art.40577
22 Ungprasert P, Koster MJ, Cheungpasitporn W, Wijarnpreecha K, Thongprayoon C, Kroner PT. Inpatient epidemiology and economic burden of granulomatosis with polyangiitis: A 10-year study of the national inpatient sample. Rheumatology. 2020;59(12):3685–9. 10.1093/rheumatology/keaa069
23 Chen M, Yu F, Zhang Y, Zhong ZW, Hui ZM, Yan WH. Characteristics of Chinese patients with Wegener’s granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int. 2005;68(5):2225–9. 10.1111/j.1523-1755.2005.00679.x
24 Pace C, Presicce M, Lamacchia F, Ferrari D, Sergiacomi G. Onset of granulomatosis with polyangiitis obscured by heart disease in an elderly man. Radiol Case Rep. 2020;15(1):54–8. 10.1016/j.radcr.2019.09.037
25 Liu X, Cui Y, Li Y, Wang C, Zhao H, Han J. Using inpatient data to estimate the prevalence of Wegener’s granulomatosis in China. Intractable Rare Dis Res. 2016;5(1):31–5. 10.5582/irdr.2015.01015
26 Naidu GSRSNK, Misra DP, Rathi M, Sharma A. Is granulomatosis with polyangiitis in Asia different from the West? Int J Rheum Dis. 2019;22(Suppl 1):90–4. 10.1111/1756-185X.13398
27 Sada K, Yamamura M, Harigai M, Fujii T, Dobashi H, Takasaki Y, et al. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther. 2014;16(2):R101. 10.1186/ar4550
28 Ono N, Niiro H, Ueda A, Sawabe T, Nishizaka H, Furugo I, et al. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: A retrospective multi-center study in Japan. Rheumatol Int. 2015;35(3):555–9. 10.1007/s00296-014-3106-z
29 Chauhan R, Jain D, Tiwari AK, Dorwal P, Raina V, Nandi SP. Laboratory diagnosis of ANCA-associated vasculitis (AAV) using a combination of immunofluorescence test (IIFT) and line immunoassay (LIA): Single-centre report from India. Reumatol Clin. 2020;S1699-258X(20):30202–3.
30 Mehrotra AK, Swami S, Soothwal P, Feroz A, Dawar S, Bhangoo HD. Pulmonary vasculitis: Indian perspective. Indian J Chest Dis Allied Sci. 2016;58(2):107–19. 10.5005/ijcdas-58-2-107
31 Ben Ghorbel I, Belfeki N, Baouendi N, Ben Salem T, Houman MH. Granulomatosis with polyangiitis in Tunisia. Reumatismo. 2017;69(1):23–9. 10.4081/reumatismo.2017.935
32 Palomino L, Gaffo A, Sun D, Sattui SE. Clinical features of ANCA-associated vasculitis in African American patients in the United States: A single-center medical records review study. J Clin Rheumatol. 2022;28(4):212–6. 10.1097/RHU.0000000000001838
33 Morales-Angulo C, García-Zornoza R, Obeso-Agüera S, Calvo-Alén J, González-Gay MA. Ear, nose and throat manifestations of Wegener’s granulomatosis (granulomatosis with polyangiitis). Acta Otorrinolaringol Esp. 2012;63(3):206–11. 10.1016/j.otoeng.2012.05.004
34 Hoffman GS, Leavitt RY, Kerr GS, Fauci AS. The treatment of Wegener’s granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum. 1992;35(11):1322–9. 10.1002/art.1780351113
35 Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med. 1992;116(6):488–98. 10.7326/0003-4819-116-6-488
36 Shobha V, Fathima S, Prakash R. Granulomatosis with polyangiitis: Clinical course and outcome of 60 patients from a single center in South India. Clin Exp Med. 2018;18(3): 347–53. 10.1007/s10238-018-0492-7
37 Pierini FS, Scolnik M, Scaglioni V, Mollerach F, Soriano ER. Incidence and prevalence of granulomatosis with polyangiitis and microscopic polyangiitis in health management organization in Argentina: A 15-year study. Clin Rheumatol. 2019;38(7):1935–40. 10.1007/s10067-019-04463-y
38 Hinojosa-Azaola A, Nuñez-Alvarez C, Uriarte C, García-Hernández J, Alcocer-Varela J. Anti-neutrophil cytoplasmic antibody-associated vasculitis in Mexican population: Clinical phenotype, autoantibody profile and renal characteristics. J Vasc. 2016;2. 10.4172/2471-9544.100110
39 Fernández-Ávila DG, Rondón-Carvajal J, Villota-Eraso C, Gutiérrez-Dávila JM, Contreras-Villamizar KM. Demographic and clinical characteristics of patients with ANCA-positive vasculitis in a Colombian University Hospital over a 12-year period: 2005–2017. Rheumatol Int. 2020;40(8):1283–90. 10.1007/s00296-020-04631-3
40 Santacruz-Sandoval E, Lopez-Bonilla J, Guevara-Calderon LA, Nieto-Aristizabal I, Ruiz-Ordonez I, Canas CAM, et al. Clinical characteristics and outcomes of patients with ANCA-associated vasculitides in a Colombian hospital. JCR. 2022;28(2). 10.1097/RHU.0000000000001775
41 de Azevedo FVA, Lima FO, de Carvalho JF, de Saboia Mont’Alverne AR, Rodrigues CEM. Granulomatosis with polyangiitis in Northeastern Brazil: Study of 25 cases and review of the literature. Adv Rheumatol. 201828;58(1):10. 10.1186/s42358-018-0010-3
42 Elgueta SF, Larrea LR, Vargas D, Wurmann P, Goecke I. AB0590 performance of 2017 ACR/EULAR provisional classification criteria for granulomatosis with polyangiitis in Chilean population. Ann Rheum Dis. 2017;76(Suppl 2):1257–8. 10.1136/annrheumdis-2017-eular.6732
43 Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, et al. Clinical features and outcome of pediatric Wegener’s granulomatosis. Arthritis Rheum. 2007;57(5):837–44. 10.1002/art.22774
44 Orazbekov L, Issergepova B, Assainova M, Ruslanuly K. Granulomatosis with polyangiitis with ocular manifestations. Case Rep Ophthalmol. 202112(1):98–104. 10.1159/000510959
45 Foster LD, Nyugen M, Margolin E. Conjunctivitis, episcleritis and anterior uveitis as the first presenting features of granulomatosis with polyangiitis. BMJ Case Rep. 2021;14(10):e243558. 10.1136/bcr-2021-243558
46 Calatroni M, Oliva E, Gianfreda D, Gregorini G, Allinovi M, Ramirez GA, et al. ANCA-associated vasculitis in childhood: Recent advances. Ital J Pediatr. 2017;43(1):46. 10.1186/s13052-017-0364-x
47 Grisaru S, Yuen GWH, Miettunen PM, Hamiwka LA. Incidence of Wegener’s granulomatosis in children. J Rheumatol. 2010;37(2):440–2. 10.3899/jrheum.090688
48 Iudici M, Quartier P, Terrier B, Mouthon L, Guillevin L, Puéchal X. Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: Systematic review and meta-analysis. Orphanet J Rare Dis. 2016;11(1):141. 10.1186/s13023-016-0523-y
49 Sacri AS, Chambaraud T, Ranchin B, Florkin B, Sée H, Decramer S, et al. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: A French nationwide study. Nephrol Dial Transplant. 2015;30(Suppl 1): i104–12. 10.1093/ndt/gfv011
50 Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, et al. Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener’s): An ARChiVe cohort study. Arthritis Rheumatol. 2016;68(10):2514–26.
51 Ralli M, Campo F, Angeletti D, Minni A, Artico M, Greco A, et al. Pathophysiology and therapy of systemic vasculitides. EXCLI J. 2020;19:817–54.
52 Xie G, Roshandel D, Sherva R, Monach PA, Lu EY, Kung T, et al. Association of granulomatosis with polyangiitis (Wegener’s) with HLA-DPB1*04 and SEMA6A gene variants: Evidence from genome-wide analysis. Arthritis Rheum. 2013;65(9):2457–68. 10.1002/art.38036
53 Kocaaga A, Kocaaga M. An immunogenetic perspective of ANCA-associated vasculitides. ERAR. 2022;49(1):14. 10.1186/s43166-022-00114-4
54 Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DRW, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367(3):214–23. 10.1056/NEJMoa1108735
55 Pendergraft WF, Preston GA, Shah RR, Tropsha A, Carter CW, Jennette JC, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 2004;10(1):72–9. 10.1038/nm968
56 Chavez Y, Garces J, Díaz R, Escobar M, Sanchez A, Buendía E, et al. Molecular mimicry among human proteinase 3 and bacterial antigens: Implications for development of c-ANCA associated vasculitis. Oxf Open Immunol. 2022;3(1):iqac009. 10.1093/oxfimm/iqac009
57 Calderwood JW, Williams JM, Morgan MD, Nash GB, Savage COS. ANCA induces beta2 integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium. J Leukoc Biol. 2005;77(1):33–43. 10.1189/jlb.0104054
58 Genuis K, Pewarchuk J. Granulomatosis with polyangiitis (Wegener’s) as a necrotizing gingivitis mimic: A case report. J Med Case Rep. 20147;8:297. 10.1186/1752-1947-8-297
59 Gomes GL, Halpern AS, Souza FHC de, Shinjo SK. Association between saddle nose deformity and retro-orbital mass in Wegener’s granulomatosis. Acta Reumatol Port. 2010;35(3):340–5.
60 Cannady SB, Batra PS, Koening C, Lorenz RR, Citardi MJ, Langford C, et al. Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases. Laryngoscope. 2009;119(4):757–61. 10.1002/lary.20161
61 Finkel R, Honig J, Chao CP, Rescoe E, Solomon S. The use of ECMO in pediatric granulomatosis with polyangiitis. Pediatr Rheumatol Online J. 2022;20(1):35. 10.1186/s12969-022-00693-8
62 Iudici M, Pagnoux C, Quartier P, Büchler M, Cevallos R, Cohen P, et al. Childhood-versus adult-onset ANCA-associated vasculitides: A nested, matched case-control study from the French Vasculitis Study Group Registry. Autoimmun Rev. 2018;17(2):108–14. 10.1016/j.autrev.2017.11.014
63 Trimarchi M, Sinico RA, Teggi R, Bussi M, Specks U, Meroni PL. Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmun Rev. 2013;12(4):501–5. 10.1016/j.autrev.2012.08.010
64 Felicetti M, Cazzador D, Padoan R, Pendolino AL, Faccioli C, Nardello E, et al. Ear, nose and throat involvement in granulomatosis with polyangiitis: How it presents and how it determines disease severity and long-term outcomes. Clin Rheumatol. 2018;37(4):1075–83. 10.1007/s10067-018-4019-0
65 Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): Clinical aspects and treatment. Autoimmun Rev. 2014;13(11):1121–5. 10.1016/j.autrev.2014.08.017
66 Yoshida N, Iino Y. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis. Allergol Int. 2014;63(4): 523–32. 10.2332/allergolint.14-RAI-0774
67 Goh KY, Bannon R, Darat HN, Ram B, Dwivedi RC. Intractable chronic otitis media, rhinosinusitis and facial palsy: A case of active granulomatosis with polyangiitis. BMJ Case Rep. 20207;13(9):e233685. 10.1136/bcr-2019-233685
68 Magliulo G, Ciniglio Appiani M, Porcaro M, Iannella G. Pneumolabyrinth following eustachian tube insufflation. Otolaryngol Head Neck Surg. 2012;147(5):980–1. 10.1177/0194599812458087
69 Belostotsky VM, Shah V, Dillon MJ. Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol. 2002;17(9):754–61. 10.1007/s00467-002-0914-2
70 Frosch M, Foell D. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr. 2004;163(8):425–34. 10.1007/s00431-004-1464-3
71 Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, et al. Wegener granulomatosis in children and adolescents: Clinical presentation and outcome. J Pediatr. 1993122(1):26–31. 10.1016/S0022-3476(05)83482-1
72 Bligny D, Mahr A, Toumelin PL, Mouthon L, Guillevin L. Predicting mortality in systemic Wegener’s granulomatosis: A survival analysis based on 93 patients. Arthritis Rheum. 200415;51(1):83–91. 10.1002/art.20082
73 Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936–41. 10.1136/ard.2005.046300
74 Yoshida N, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, et al. Reversible cochlear function with ANCA-associated vasculitis initially diagnosed by otologic symptoms. Otol Neurotol. 2014;35(1):114–20. 10.1097/MAO.0000000000000175
75 Kousha A, Reed M, Else S. Isolated deafness as a presenting symptom in granulomatosis with polyangiitis. BMJ Case Rep. 2021;14(3):e241159. 10.1136/bcr-2020-241159
76 Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener’s granulomatosis. Ophthalmology. 1983;90(3):279–90. 10.1016/S0161-6420(83)34574-7
77 Leavitt JA, Butrus SI. Wegener’s granulomatosis presenting as dacryoadenitis. Cornea. 1991;10(6):542–5. 10.1097/00003226-199111000-00015
78 Perry SR, Rootman J, White VA. The clinical and pathologic constellation of Wegener granulomatosis of the orbit. Ophthalmology. 1997;104(4):683–94. 10.1016/S0161-6420(97)30251-6
79 Lutalo PMK, D’Cruz DP. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis). J Autoimmun. 2014;48–49:94–8. 10.1016/j.jaut.2014.01.028
80 Wat J, Wat M, Honda K. Granulomatosis with polyangiitis presenting as palpable purpura with sinusitis, hemoptysis, and lung cavitation. J Cutan Pathol. 2020;47(5):421–4. 10.1111/cup.13632
81 Szymanowska-Narloch A, Gawryluk D, Błasińska-Przerwa K, Siemińska A. Atypical manifestations of granulomatosis with polyangiitis: The diagnostic challenge for pulmonologists. Adv Respir Med. 2019;87(6):244–53. 10.5603/ARM.2019.0062
82 Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C, et al. Early mortality in systemic vasculitis: Relative contribution of adverse events and active vasculitis. Ann Rheum Dis. 2010;69(6):1036–43. 10.1136/ard.2009.109389
83 Zhang W, Zhou G, Shi Q, Zhang X, Zeng XF, Zhang FC. Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol. 2009;27(1 Suppl 52):S65–9.
84 Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L. Central nervous system involvement in Wegener granulomatosis. Medicine. 2006;85(1):53–65. 10.1097/01.md.0000200166.90373.41
85 Pawlitzki M, Perosa V, Korsen M, Mawrin C, Bartels C, Huchtemann T. Aggressive spinal cord involvement in granulomatosis with polyangiitis. Int J Rheum Dis. 2019;22(4): 756–8. 10.1111/1756-185X.13561
86 Gasparinho R, Fernandes N, Martins M, Santos N, Ferreira LP, Alho A. Psychosis as the first manifestation of granulomatosis with polyangiitis–A case report. Psychiatr Danub. 2022;34(2):315–7. 10.24869/psyd.2022.315
87 Verma S, Joshi R, Shah R. Acne fulminans in a young man with granulomatosis with polyangiitis (Wegener’s granulomatosis): A chance association or marker of serious systemic disease? Indian J Dermatol Venereol Leprol. 2020;86(6): 669–73. 10.4103/ijdvl.IJDVL_155_18
88 Gajic-Veljic M, Nikolic M, Peco-Antic A, Bogdanovic R, Andrejevic S, Bonaci-Nikolic B. Granulomatosis with polyangiitis (Wegener’s granulomatosis) in children: Report of three cases with cutaneous manifestations and literature review. Pediatr Dermatol. 2013;30(4):e37–42. 10.1111/pde.12034
89 Fotis L, Prountzos S, Giannouli G, Papaevangelou V. Facial necrotic ulcerative lesions in an adolescent female with granulomatosis with polyangiitis (GPA). Clin Rheumatol. 2020;39(11):3519–20. 10.1007/s10067-020-05264-4
90 Jamali Moghadam SR, Salehi MR, Mojtahedi SY, Fadaei N, Dadras O, SeyedAlinaghi S, et al. Granulomatosis with polyangiitis (GPA) in a 15-year-old girl with facial acne-like ulcers: A case report. Infect Disord Drug Targets. 2020;20(6):932–6. 10.2174/1871526519666191115105036
91 Sekeres J, Bruzzese JM, John RM. An adolescent male with a nonhealing leg ulcer: A case of granulomatosis with polyangiitis. Nurse Pract. 2018;43(11):18–23. 10.1097/01.NPR.0000546446.86603.2f
92 Moen BH, Nystad TW, Barrett TM, Sandvik LF. A boy in his teens with large ulcerations of the head and neck. Tidsskr Nor Laegeforen. 2019;139(7).
93 Arfaoui H, Elkihal H, Jabri H, Elkhattabi W, Afif H. Adolescent with severe granulomatosis with polyangiitis: a case report. Pan Afr Med J. 2021;38:285. 10.11604/pamj.2021.38.285.26893
94 Bui T, Chandrakasan S, Poulik J, Fathalla BM. Granulomatosis with polyangiitis presenting as Henoch-Schönlein purpura in children. J Clin Rheumatol. 2013;19(4):199–202. 10.1097/RHU.0b013e318293aff5
95 Sarlon G, Durant C, Grandgeorge Y, Bernit E, Veit V, Hamidou M, et al. Cardiac involvement in Wegener’s granulomatosis: Report of four cases and review of the literature. Rev Med Interne. 2010;31(2):135–9. 10.1016/j.revmed.2009.06.007
96 Grant SC, Levy RD, Venning MC, Ward C, Brooks NH. Wegener’s granulomatosis and the heart. Heart. 1994;71(1):82–6. 10.1136/hrt.71.1.82
97 Hirata M, Miyazawa H, Morino J, Kaneko S, Minato S, Katsunori Y, et al. A case report of PR-3-ANCA-positive glomerulonephritis with histological features of GPA associated with infectious endocarditis. Medicine. 2021;100(32):e26905. 10.1097/MD.0000000000026905
98 Merkel PA, Lo GH, Holbrook JT, Tibbs AK, Allen NB, Davis JC, et al. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: The Wegener’s clinical occurrence of thrombosis (WeCLOT) study. Ann Intern Med. 2005;142(8):620–6. 10.7326/0003-4819-142-8-200505030-00011
99 Allenbach Y, Seror R, Pagnoux C, Teixeira L, Guilpain P, Guillevin L, et al. High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: A systematic retrospective study on 1130 patients. Ann Rheum Dis. 2009;68(4):564–7. 10.1136/ard.2008.099051
100 Isaacs B, Gapud EJ, Antiochos B, Seo P, Geetha D. Venous thrombotic events in ANCA-associated vasculitis: Incidence and risk factors. Kidney360. 2020;1(4):258–62. 10.34067/KID.0000572019
101 Pan L, Yan JH, Gao FQ, Li H, Han SS, Cao GH, et al. Case report of a 28-year-old man with aortic dissection and pulmonary shadow due to granulomatosis with polyangiitis. BMC Pulm Med. 2019;19(1):122. 10.1186/s12890-019-0884-9
102 Rehani C, Nelson JS. Coronary artery aneurysms as a feature of granulomatosis with polyangiitis. Pediatrics. 2021;147(1):e20200932. 10.1542/peds.2020-0932
103 Deniz K, Ozşeker HS, Balas S, Akpýnar E, Sökmensüer C. Intestinal involvement in Wegener’s granulomatosis. J Gastrointestin Liver Dis. 2007;16(3):329–31.
104 Yildirim AC, Koçak E, Yildiz P, Yildiz M, Karakayali AŞ, Kaptanoglu B, et al. Multiple intestinal perforation in a patient with Wegener’s granulomatosis: a case report and review of the literature. Gastroenterol Clin Biol. 2010 Dec;34(12):712–5. 10.1016/j.gcb.2010.08.009
105 Yasin S, Mehmood K. Recurrent gastrointestinal bleeding due to jejunal artery vasculitis as debut presentation of granulomatosis with polyangiitis. BMJ Case Rep. 2021;14(1):e237876. 10.1136/bcr-2020-237876
106 Gu X, Ma L, Shi M, Chi S, Huang L. A case of Wegener’s granulomatosis presenting with gastrointestinal bleeding. Gastroenterol Nurs. 2021;44(6):455–7. 10.1097/SGA.0000000000000567
107 Rees DO, Gunavardhan A, Glover DA. Granulomatosis with polyangiitis: an unusual cause of acute liver injury. BMJ Case Rep. 2018;2018:bcr-2017-222464. 10.1136/bcr-2017-222464
108 Tyagi S, Bajpai G. Acute pancreatitis: An atypical presentation of granulomatosis with polyangiitis. Rheumatology. 2021; 60(3):e83–4. 10.1093/rheumatology/keaa513
109 Garbe N, Keyßer G, Schäfer C, Garbe J. Pancreatitis as the leading manifestation of granulomatosis with polyangiitis: Case report and review of the literature. Pancreas. 2021;50(10):e85–8. 10.1097/MPA.0000000000001944
110 Vega-Beyhart A, Medina-Rangel IR, Hinojosa-Azaola A, Fernández-Barrio M, Vargas-Castro AS, García-Inciarte L, et al. Pituitary dysfunction in granulomatosis with polyangiitis. Clin Rheumatol. 2020;39(2):595–606. 10.1007/s10067-019-04735-7
111 Gu Y, Sun X, Peng M, Zhang T, Shi J, Mao J. Pituitary involvement in patients with granulomatosis with polyangiitis: Case series and literature review. Rheumatol Int. 2019;39(8):1467–76. 10.1007/s00296-019-04338-0
112 Kapoor E, Cartin-Ceba R, Specks U, Leavitt J, Erickson B, Erickson D. Pituitary dysfunction in granulomatosis with polyangiitis: The Mayo Clinic experience. J Clin Endocrinol Metab. 2014;99(11):3988–94. 10.1210/jc.2014-1962
113 Piper K, Beldick SR, Karsy M, Allawh T, Shirodkar M, Miller J, et al. Granulomatosis with polyangiitis masquerading as pituitary adenoma with apoplexy. Mod Rheumatol Case Rep. 2021;5(2):342–6. 10.1080/24725625.2021.1909222
114 Trives-Folguera L, Isenberg D. A curious case of granulomatosis with polyangiitis: Prostatic and skin involvement. Rheumatol Adv Pract. 2022;6(2):rkac033. 10.1093/rap/rkac033
115 Ahmadnia H, Hasanzadeh Haddad A, Darabi Mahboub MR, Akhavan Rezayat AR. A nonspecific penile ulcer leading to the diagnosis of Wegener’s granulomatosis. Urol J. 2020;17(2):210–2.
116 Ahmed HMA, Elfishawi MM, Hagiga A, Ahmed IMA, Chen YL. Urethral involvement in granulomatosis with polyangiitis: A case-based review. Rheumatol Int. 2019;39(7):1279–84. 10.1007/s00296-019-04331-7
117 Jarrot PA, Pelletier ML, Brun M, Penicaud M, Mazodier K, Benyamine A, et al. Bilateral breast ulcers: Granulomatosis with polyangiitis. Am J Med. 2019;132(2):179–81. 10.1016/j.amjmed.2018.09.008
118 Cagan M, Fadiloglu E, Unal C, Beksac MS. Granulomatosis with polyangiitis and pregnancy: Anti-neutrophil cytoplasmic antibody, placental inflammation, chorangiosis and pre-eclampsia. J Obstet Gynaecol Res. 2020;46(9):1907–10. 10.1111/jog.14356
119 Folci M, Ramponi G, Shiffer D, Zumbo A, Agosti M, Brunetta E. ANCA-associated vasculitides and hematologic malignancies: Lessons from the past and future perspectives. J Immunol Res. 2019;2019:1732175. 10.1155/2019/1732175
120 Mohammed T, Thomas S, Sepúlveda-Ramos M, Premkumar P, Glomski K, Dailey M, et al. Granulomatosis with polyangiitis associated with hemophagocytic lymphohistiocytosis. J Clin Rheumatol. 2021;27(8 Suppl):S827–8. 10.1097/RHU.0000000000001432
121 Rezac J, Honsova E, Masek M, Rysava R, Neprasova M, Jancova E, et al. Granulomatosis with polyangiitis mimicking cancer: A diagnostic dilemma. J Nephrol. 2022;35(2):675–8. 10.1007/s40620-021-01128-5
122 Gendelman O, Kuntzman Y, Shovman O, Langevitz P, Tsur AM, Erez D, et al. Tumor-like lesions in patients with granulomatosis with polyangiitis: A case series. Isr Med Assoc J. 2021;23(6):350–2.
123 Tian Y, Zhang Y, Wen B, Li C, He Y. 18F-FDG PET/CT findings of granulomatosis with polyangiitis mimicking malignant lymphoma. J Clin Rheumatol. 2021;27(5):e194–5. 10.1097/RHU.0000000000001363
124 Piccirilli G, Chiereghin A, Maritati M, Turello G, Felici S, La Corte R, et al. Multidrug-resistant cytomegalovirus infection in a patient with granulomatosis with polyangiitis during immunosuppressive treatment. Antivir Ther. 2020;25(2):111–4. 10.3851/IMP3352
125 Soriano A, Smerieri N, Bonilauri S, De Marco L, Cavazza A, Salvarani C. Colonic perforation due to severe cytomegalovirus disease in granulomatosis with polyangiitis after immunosuppression. Clin Rheumatol. 2018;37(5):1427–32. 10.1007/s10067-017-3945-6
126 Morishita M, Sada KE, Matsumoto Y, Hayashi K, Asano Y, Hiramatsu Asano S, et al. Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis. PLoS One. 2019;14(7):e0218705. 10.1371/journal.pone.0218705
127 Reddy S, Tyagi M, Behera S, Pappuru RR. Cytomegalovirus retinitis in a patient of granulomatosis with polyangiitis on long-term immunosuppressants. BMJ Case Rep. 2021;14(2):e236632. 10.1136/bcr-2020-236632
128 Kariv R, Sidi Y, Gur H. Systemic vasculitis presenting as a tumorlike lesion. Four case reports and an analysis of 79 reported cases. Medicine. 2000;79(6):349–59. 10.1097/00005792-200011000-00001
129 Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: A systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis. 2008;67(7):1004–10. 10.1136/ard.2007.071936
130 Chaigne B, Guillevin L. Unsolved questions and concerns about treatment of anti-neutrophil cytoplasm antibody-associated vasculitides. Clin Exp Rheumatol. 2016;34(3 Suppl 97):S121–8.
131 Elefante E, Monti S, Bond M, Lepri G, Quartuccio L, Talarico R, et al. One year in review 2017: Systemic vasculitis. Clin Exp Rheumatol. 2017;35 Suppl 103(1):5–26.
132 Tan JA, Dehghan N, Chen W, Xie H, Esdaile JM, Avina-Zubieta JA. Mortality in ANCA-associated vasculitis: A meta-analysis of observational studies. Ann Rheum Dis. 2017;76(9):1566–74. 10.1136/annrheumdis-2016-210942
133 Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med. 1989;111(1):28–40. 10.7326/0003-4819-111-1-28
134 Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan SM, et al. Mechanisms of autoantibody-induced pathology. Front Immunol. 2017;8:603. 10.3389/fimmu.2017.00603
135 Damoiseaux J, Csernok E, Rasmussen N, Moosig F, van Paassen P, Baslund B, et al. Detection of antineutrophil cytoplasmic antibodies (ANCAs): A multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Ann Rheum Dis. 2017;76(4):647–53. 10.1136/annrheumdis-2016-209507
136 Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005;143(9):621–31. 10.7326/0003-4819-143-9-200511010-00005
137 Walsh M, Flossmann O, Berden A, Westman K, Höglund P, Stegeman C, et al. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2012;64(2):542–8. 10.1002/art.33361
138 Cornec D, Gall ECL, Fervenza FC, Specks U. ANCA-associated vasculitis—clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol. 2016;12(10):570–9. 10.1038/nrrheum.2016.123
139 Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis. 2022;81(3):315–20. 10.1002/art.41986
140 Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, et al. American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. 2022;81(3):309–14. 10.1002/art.41982
141 Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, et al. American College of Rheumatology/European Alliance of Associations for rheumatology classification criteria for microscopic polyangiitis. Arthritis Rheumatol. 2022;74(3):400–6. 10.1002/art.41983
142 Pyo JY, Lee LE, Park YB, Lee SW. Comparison of the 2022 ACR/EULAR classification criteria for antineutrophil cytoplasmic antibody-associated vasculitis with previous criteria. Yonsei Med J. 2023;64(1):11–7. 10.3349/ymj.2022.0435
143 Monach PA. Biomarkers in vasculitis. Curr Opin Rheumatol. 2014;26(1):24. 10.1097/BOR.0000000000000009
144 Kenison JE, Stevens NA, Quintana FJ. Therapeutic induction of antigen-specific immune tolerance. Nat Rev Immunol. 2024;24(5):338–57. 10.1038/s41577-023-00970-x
145 Lodka D, Zschummel M, Bunse M, Rousselle A, Sonnemann J, Kettritz R, et al. CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury. Ann Rheum Dis. 2024;83(4):499–507. 10.1136/ard-2023-224875
146 Ueda N, Cahen M, Leonard J, Deleurme L, Dreano S, Sirac C, et al. Single-hit genome editing optimized for maturation in B cells redirects their specificity toward tumor antigens. Sci Rep. 2024;14(1):22432. 10.1038/s41598-024-74005-3
147 Longhurst HJ, Lindsay K, Petersen RS, Fijen LM, Gurugama P, Maag D, et al. CRISPR-Cas9 in vivo gene editing of KLKB1 for hereditary angioedema. N Engl J Med. 2024;390(5):432–41. 10.1056/NEJMoa2309149
148 Sadeghpour Heravi F. Gut microbiota and autoimmune diseases: Mechanisms, treatment, challenges, and future recommendations. Curr Clin Micro Rpt. 2024;11(1):18–33. 10.1007/s40588-023-00213-6
149 Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359(6380):1156–61. 10.1126/science.aar7201
2 Crisford H, Sapey E, Stockley RA. Proteinase 3: A potential target in chronic obstructive pulmonary disease and other chronic inflammatory diseases. Respir Res. 2018;19(1):180. 10.1186/s12931-018-0883-z
3 Jennette JC. Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol. 2013;17(5):603–6. 10.1007/s10157-013-0869-6
4 Bossuyt X, Cohen Tervaert JW, Arimura Y, Blockmans D, Flores-Suárez LF, Guillevin L, et al. Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol. 2017;13(11):683–92. 10.1038/nrrheum.2017.140
5 Arnold S, Kitching AR, Witko-Sarsat V, Wiech T, Specks U, Klapa S, et al. Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis. Lancet Rheumatol. 2024;6(5):e300–13. 10.1016/S2665-9913(24)00025-0
6 Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997;337(21):1512–23. 10.1056/NEJM199711203372106
7 Kettritz R. How anti-neutrophil cytoplasmic autoantibodies activate neutrophils. Clin Exp Immunol. 2012;169(3):220–8. 10.1111/j.1365-2249.2012.04615.x
8 Jennette JC, Falk RJ. Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease. Nat Rev Rheumatol. 2014;10(8):463–73. 10.1038/nrrheum.2014.103
9 Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1–11. 10.1002/art.37715
10 Choi CB, Park YB, Lee SW. Antineutrophil cytoplasmic antibody-associated vasculitis in Korea: A Narrative Review. Yonsei Med J. 2019;60(1):10–21. 10.3349/ymj.2019.60.1.10
11 Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum. 1994;37(2):187–92. 10.1002/art.1780370206
12 Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66(2):222–7. 10.1136/ard.2006.054593
13 Kitching AR, Anders HJ, Basu N, Brouwer E, Gordon J, Jayne DR, et al. ANCA-associated vasculitis. Nat Rev Dis Primers. 2020;6(1):1–27. 10.1038/s41572-020-0204-y
14 Falde SD, Fussner LA, Tazelaar HD, O’Brien EK, Lamprecht P, Konig MF, et al. Proteinase 3-specific antineutrophil cytoplasmic antibody-associated vasculitis. Lancet Rheumatol. 2024;6(5):e314–27. 10.1016/S2665-9913(24)00035-3
15 Cabral DA, Uribe AG, Benseler S, O’Neil KM, Hashkes PJ, Higgins G, et al. Classification, presentation, and initial treatment of Wegener’s granulomatosis in childhood. Arthritis Rheum. 2009;60(11):3413–24. 10.1002/art.24876
16 Fujimoto S, Watts RA, Kobayashi S, Suzuki K, Jayne DRW, Scott DGI, et al. Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the UK. Rheumatology. 2011;50(10):1916–20. 10.1093/rheumatology/ker205
17 Wu CS, Hsieh CJ, Peng YS, Chang TH, Wu ZY. Antineutrophil cytoplasmic antibody-associated vasculitis in Taiwan: A hospital-based study with reference to the population-based National Health Insurance database. J Microbiol Immunol Infect. 2015;48(5):477–82. 10.1016/j.jmii.2013.12.006
18 Lamprecht P, Kerstein A, Klapa S, Schinke S, Karsten CM, Yu X, et al. Pathogenetic and clinical aspects of anti-neutrophil cytoplasmic autoantibody-associated vasculitides. Frontiers in immunology [Internet]. 2018 Sep 4 [cited 2023 Jul 24]; 9. Available from: https://pubmed.ncbi.nlm.nih.gov/29686675/
19 Berti A, Cornec D, Crowson CS, Specks U, Matteson EL. The epidemiology of antineutrophil cytoplasmic autoantibody-associated vasculitis in Olmsted County, Minnesota: A twenty-year US population-based study. Arthritis Rheumatol. 2017;69(12):2338–50. 10.1002/art.40313
20 Ntatsaki E, Watts RA, Scott DGI. Epidemiology of ANCA-associated vasculitis. Rheum Dis Clin North Am. 2010;36(3):447–61. 10.1016/j.rdc.2010.04.002
21 Panupattanapong S, Stwalley DL, White AJ, Olsen MA, French AR, Hartman ME. Epidemiology and outcomes of granulomatosis With polyangiitis in pediatric and working-age adult populations in the United States: Analysis of a large national claims database. Arthritis Rheumatol. 2018;70(12):2067–76. 10.1002/art.40577
22 Ungprasert P, Koster MJ, Cheungpasitporn W, Wijarnpreecha K, Thongprayoon C, Kroner PT. Inpatient epidemiology and economic burden of granulomatosis with polyangiitis: A 10-year study of the national inpatient sample. Rheumatology. 2020;59(12):3685–9. 10.1093/rheumatology/keaa069
23 Chen M, Yu F, Zhang Y, Zhong ZW, Hui ZM, Yan WH. Characteristics of Chinese patients with Wegener’s granulomatosis with anti-myeloperoxidase autoantibodies. Kidney Int. 2005;68(5):2225–9. 10.1111/j.1523-1755.2005.00679.x
24 Pace C, Presicce M, Lamacchia F, Ferrari D, Sergiacomi G. Onset of granulomatosis with polyangiitis obscured by heart disease in an elderly man. Radiol Case Rep. 2020;15(1):54–8. 10.1016/j.radcr.2019.09.037
25 Liu X, Cui Y, Li Y, Wang C, Zhao H, Han J. Using inpatient data to estimate the prevalence of Wegener’s granulomatosis in China. Intractable Rare Dis Res. 2016;5(1):31–5. 10.5582/irdr.2015.01015
26 Naidu GSRSNK, Misra DP, Rathi M, Sharma A. Is granulomatosis with polyangiitis in Asia different from the West? Int J Rheum Dis. 2019;22(Suppl 1):90–4. 10.1111/1756-185X.13398
27 Sada K, Yamamura M, Harigai M, Fujii T, Dobashi H, Takasaki Y, et al. Classification and characteristics of Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study. Arthritis Res Ther. 2014;16(2):R101. 10.1186/ar4550
28 Ono N, Niiro H, Ueda A, Sawabe T, Nishizaka H, Furugo I, et al. Characteristics of MPO-ANCA-positive granulomatosis with polyangiitis: A retrospective multi-center study in Japan. Rheumatol Int. 2015;35(3):555–9. 10.1007/s00296-014-3106-z
29 Chauhan R, Jain D, Tiwari AK, Dorwal P, Raina V, Nandi SP. Laboratory diagnosis of ANCA-associated vasculitis (AAV) using a combination of immunofluorescence test (IIFT) and line immunoassay (LIA): Single-centre report from India. Reumatol Clin. 2020;S1699-258X(20):30202–3.
30 Mehrotra AK, Swami S, Soothwal P, Feroz A, Dawar S, Bhangoo HD. Pulmonary vasculitis: Indian perspective. Indian J Chest Dis Allied Sci. 2016;58(2):107–19. 10.5005/ijcdas-58-2-107
31 Ben Ghorbel I, Belfeki N, Baouendi N, Ben Salem T, Houman MH. Granulomatosis with polyangiitis in Tunisia. Reumatismo. 2017;69(1):23–9. 10.4081/reumatismo.2017.935
32 Palomino L, Gaffo A, Sun D, Sattui SE. Clinical features of ANCA-associated vasculitis in African American patients in the United States: A single-center medical records review study. J Clin Rheumatol. 2022;28(4):212–6. 10.1097/RHU.0000000000001838
33 Morales-Angulo C, García-Zornoza R, Obeso-Agüera S, Calvo-Alén J, González-Gay MA. Ear, nose and throat manifestations of Wegener’s granulomatosis (granulomatosis with polyangiitis). Acta Otorrinolaringol Esp. 2012;63(3):206–11. 10.1016/j.otoeng.2012.05.004
34 Hoffman GS, Leavitt RY, Kerr GS, Fauci AS. The treatment of Wegener’s granulomatosis with glucocorticoids and methotrexate. Arthritis Rheum. 1992;35(11):1322–9. 10.1002/art.1780351113
35 Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Lebovics RS, Travis WD, et al. Wegener granulomatosis: An analysis of 158 patients. Ann Intern Med. 1992;116(6):488–98. 10.7326/0003-4819-116-6-488
36 Shobha V, Fathima S, Prakash R. Granulomatosis with polyangiitis: Clinical course and outcome of 60 patients from a single center in South India. Clin Exp Med. 2018;18(3): 347–53. 10.1007/s10238-018-0492-7
37 Pierini FS, Scolnik M, Scaglioni V, Mollerach F, Soriano ER. Incidence and prevalence of granulomatosis with polyangiitis and microscopic polyangiitis in health management organization in Argentina: A 15-year study. Clin Rheumatol. 2019;38(7):1935–40. 10.1007/s10067-019-04463-y
38 Hinojosa-Azaola A, Nuñez-Alvarez C, Uriarte C, García-Hernández J, Alcocer-Varela J. Anti-neutrophil cytoplasmic antibody-associated vasculitis in Mexican population: Clinical phenotype, autoantibody profile and renal characteristics. J Vasc. 2016;2. 10.4172/2471-9544.100110
39 Fernández-Ávila DG, Rondón-Carvajal J, Villota-Eraso C, Gutiérrez-Dávila JM, Contreras-Villamizar KM. Demographic and clinical characteristics of patients with ANCA-positive vasculitis in a Colombian University Hospital over a 12-year period: 2005–2017. Rheumatol Int. 2020;40(8):1283–90. 10.1007/s00296-020-04631-3
40 Santacruz-Sandoval E, Lopez-Bonilla J, Guevara-Calderon LA, Nieto-Aristizabal I, Ruiz-Ordonez I, Canas CAM, et al. Clinical characteristics and outcomes of patients with ANCA-associated vasculitides in a Colombian hospital. JCR. 2022;28(2). 10.1097/RHU.0000000000001775
41 de Azevedo FVA, Lima FO, de Carvalho JF, de Saboia Mont’Alverne AR, Rodrigues CEM. Granulomatosis with polyangiitis in Northeastern Brazil: Study of 25 cases and review of the literature. Adv Rheumatol. 201828;58(1):10. 10.1186/s42358-018-0010-3
42 Elgueta SF, Larrea LR, Vargas D, Wurmann P, Goecke I. AB0590 performance of 2017 ACR/EULAR provisional classification criteria for granulomatosis with polyangiitis in Chilean population. Ann Rheum Dis. 2017;76(Suppl 2):1257–8. 10.1136/annrheumdis-2017-eular.6732
43 Akikusa JD, Schneider R, Harvey EA, Hebert D, Thorner PS, Laxer RM, et al. Clinical features and outcome of pediatric Wegener’s granulomatosis. Arthritis Rheum. 2007;57(5):837–44. 10.1002/art.22774
44 Orazbekov L, Issergepova B, Assainova M, Ruslanuly K. Granulomatosis with polyangiitis with ocular manifestations. Case Rep Ophthalmol. 202112(1):98–104. 10.1159/000510959
45 Foster LD, Nyugen M, Margolin E. Conjunctivitis, episcleritis and anterior uveitis as the first presenting features of granulomatosis with polyangiitis. BMJ Case Rep. 2021;14(10):e243558. 10.1136/bcr-2021-243558
46 Calatroni M, Oliva E, Gianfreda D, Gregorini G, Allinovi M, Ramirez GA, et al. ANCA-associated vasculitis in childhood: Recent advances. Ital J Pediatr. 2017;43(1):46. 10.1186/s13052-017-0364-x
47 Grisaru S, Yuen GWH, Miettunen PM, Hamiwka LA. Incidence of Wegener’s granulomatosis in children. J Rheumatol. 2010;37(2):440–2. 10.3899/jrheum.090688
48 Iudici M, Quartier P, Terrier B, Mouthon L, Guillevin L, Puéchal X. Childhood-onset granulomatosis with polyangiitis and microscopic polyangiitis: Systematic review and meta-analysis. Orphanet J Rare Dis. 2016;11(1):141. 10.1186/s13023-016-0523-y
49 Sacri AS, Chambaraud T, Ranchin B, Florkin B, Sée H, Decramer S, et al. Clinical characteristics and outcomes of childhood-onset ANCA-associated vasculitis: A French nationwide study. Nephrol Dial Transplant. 2015;30(Suppl 1): i104–12. 10.1093/ndt/gfv011
50 Cabral DA, Canter DL, Muscal E, Nanda K, Wahezi DM, Spalding SJ, et al. Comparing presenting clinical features in 48 children with microscopic polyangiitis to 183 children who have granulomatosis with polyangiitis (Wegener’s): An ARChiVe cohort study. Arthritis Rheumatol. 2016;68(10):2514–26.
51 Ralli M, Campo F, Angeletti D, Minni A, Artico M, Greco A, et al. Pathophysiology and therapy of systemic vasculitides. EXCLI J. 2020;19:817–54.
52 Xie G, Roshandel D, Sherva R, Monach PA, Lu EY, Kung T, et al. Association of granulomatosis with polyangiitis (Wegener’s) with HLA-DPB1*04 and SEMA6A gene variants: Evidence from genome-wide analysis. Arthritis Rheum. 2013;65(9):2457–68. 10.1002/art.38036
53 Kocaaga A, Kocaaga M. An immunogenetic perspective of ANCA-associated vasculitides. ERAR. 2022;49(1):14. 10.1186/s43166-022-00114-4
54 Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DRW, et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med. 2012;367(3):214–23. 10.1056/NEJMoa1108735
55 Pendergraft WF, Preston GA, Shah RR, Tropsha A, Carter CW, Jennette JC, et al. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 2004;10(1):72–9. 10.1038/nm968
56 Chavez Y, Garces J, Díaz R, Escobar M, Sanchez A, Buendía E, et al. Molecular mimicry among human proteinase 3 and bacterial antigens: Implications for development of c-ANCA associated vasculitis. Oxf Open Immunol. 2022;3(1):iqac009. 10.1093/oxfimm/iqac009
57 Calderwood JW, Williams JM, Morgan MD, Nash GB, Savage COS. ANCA induces beta2 integrin and CXC chemokine-dependent neutrophil-endothelial cell interactions that mimic those of highly cytokine-activated endothelium. J Leukoc Biol. 2005;77(1):33–43. 10.1189/jlb.0104054
58 Genuis K, Pewarchuk J. Granulomatosis with polyangiitis (Wegener’s) as a necrotizing gingivitis mimic: A case report. J Med Case Rep. 20147;8:297. 10.1186/1752-1947-8-297
59 Gomes GL, Halpern AS, Souza FHC de, Shinjo SK. Association between saddle nose deformity and retro-orbital mass in Wegener’s granulomatosis. Acta Reumatol Port. 2010;35(3):340–5.
60 Cannady SB, Batra PS, Koening C, Lorenz RR, Citardi MJ, Langford C, et al. Sinonasal Wegener granulomatosis: a single-institution experience with 120 cases. Laryngoscope. 2009;119(4):757–61. 10.1002/lary.20161
61 Finkel R, Honig J, Chao CP, Rescoe E, Solomon S. The use of ECMO in pediatric granulomatosis with polyangiitis. Pediatr Rheumatol Online J. 2022;20(1):35. 10.1186/s12969-022-00693-8
62 Iudici M, Pagnoux C, Quartier P, Büchler M, Cevallos R, Cohen P, et al. Childhood-versus adult-onset ANCA-associated vasculitides: A nested, matched case-control study from the French Vasculitis Study Group Registry. Autoimmun Rev. 2018;17(2):108–14. 10.1016/j.autrev.2017.11.014
63 Trimarchi M, Sinico RA, Teggi R, Bussi M, Specks U, Meroni PL. Otorhinolaryngological manifestations in granulomatosis with polyangiitis (Wegener’s). Autoimmun Rev. 2013;12(4):501–5. 10.1016/j.autrev.2012.08.010
64 Felicetti M, Cazzador D, Padoan R, Pendolino AL, Faccioli C, Nardello E, et al. Ear, nose and throat involvement in granulomatosis with polyangiitis: How it presents and how it determines disease severity and long-term outcomes. Clin Rheumatol. 2018;37(4):1075–83. 10.1007/s10067-018-4019-0
65 Comarmond C, Cacoub P. Granulomatosis with polyangiitis (Wegener): Clinical aspects and treatment. Autoimmun Rev. 2014;13(11):1121–5. 10.1016/j.autrev.2014.08.017
66 Yoshida N, Iino Y. Pathogenesis and diagnosis of otitis media with ANCA-associated vasculitis. Allergol Int. 2014;63(4): 523–32. 10.2332/allergolint.14-RAI-0774
67 Goh KY, Bannon R, Darat HN, Ram B, Dwivedi RC. Intractable chronic otitis media, rhinosinusitis and facial palsy: A case of active granulomatosis with polyangiitis. BMJ Case Rep. 20207;13(9):e233685. 10.1136/bcr-2019-233685
68 Magliulo G, Ciniglio Appiani M, Porcaro M, Iannella G. Pneumolabyrinth following eustachian tube insufflation. Otolaryngol Head Neck Surg. 2012;147(5):980–1. 10.1177/0194599812458087
69 Belostotsky VM, Shah V, Dillon MJ. Clinical features in 17 paediatric patients with Wegener granulomatosis. Pediatr Nephrol. 2002;17(9):754–61. 10.1007/s00467-002-0914-2
70 Frosch M, Foell D. Wegener granulomatosis in childhood and adolescence. Eur J Pediatr. 2004;163(8):425–34. 10.1007/s00431-004-1464-3
71 Rottem M, Fauci AS, Hallahan CW, Kerr GS, Lebovics R, Leavitt RY, et al. Wegener granulomatosis in children and adolescents: Clinical presentation and outcome. J Pediatr. 1993122(1):26–31. 10.1016/S0022-3476(05)83482-1
72 Bligny D, Mahr A, Toumelin PL, Mouthon L, Guillevin L. Predicting mortality in systemic Wegener’s granulomatosis: A survival analysis based on 93 patients. Arthritis Rheum. 200415;51(1):83–91. 10.1002/art.20082
73 Ozen S, Ruperto N, Dillon MJ, Bagga A, Barron K, Davin JC, et al. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides. Ann Rheum Dis. 2006;65(7):936–41. 10.1136/ard.2005.046300
74 Yoshida N, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, et al. Reversible cochlear function with ANCA-associated vasculitis initially diagnosed by otologic symptoms. Otol Neurotol. 2014;35(1):114–20. 10.1097/MAO.0000000000000175
75 Kousha A, Reed M, Else S. Isolated deafness as a presenting symptom in granulomatosis with polyangiitis. BMJ Case Rep. 2021;14(3):e241159. 10.1136/bcr-2020-241159
76 Bullen CL, Liesegang TJ, McDonald TJ, DeRemee RA. Ocular complications of Wegener’s granulomatosis. Ophthalmology. 1983;90(3):279–90. 10.1016/S0161-6420(83)34574-7
77 Leavitt JA, Butrus SI. Wegener’s granulomatosis presenting as dacryoadenitis. Cornea. 1991;10(6):542–5. 10.1097/00003226-199111000-00015
78 Perry SR, Rootman J, White VA. The clinical and pathologic constellation of Wegener granulomatosis of the orbit. Ophthalmology. 1997;104(4):683–94. 10.1016/S0161-6420(97)30251-6
79 Lutalo PMK, D’Cruz DP. Diagnosis and classification of granulomatosis with polyangiitis (aka Wegener’s granulomatosis). J Autoimmun. 2014;48–49:94–8. 10.1016/j.jaut.2014.01.028
80 Wat J, Wat M, Honda K. Granulomatosis with polyangiitis presenting as palpable purpura with sinusitis, hemoptysis, and lung cavitation. J Cutan Pathol. 2020;47(5):421–4. 10.1111/cup.13632
81 Szymanowska-Narloch A, Gawryluk D, Błasińska-Przerwa K, Siemińska A. Atypical manifestations of granulomatosis with polyangiitis: The diagnostic challenge for pulmonologists. Adv Respir Med. 2019;87(6):244–53. 10.5603/ARM.2019.0062
82 Little MA, Nightingale P, Verburgh CA, Hauser T, De Groot K, Savage C, et al. Early mortality in systemic vasculitis: Relative contribution of adverse events and active vasculitis. Ann Rheum Dis. 2010;69(6):1036–43. 10.1136/ard.2009.109389
83 Zhang W, Zhou G, Shi Q, Zhang X, Zeng XF, Zhang FC. Clinical analysis of nervous system involvement in ANCA-associated systemic vasculitides. Clin Exp Rheumatol. 2009;27(1 Suppl 52):S65–9.
84 Seror R, Mahr A, Ramanoelina J, Pagnoux C, Cohen P, Guillevin L. Central nervous system involvement in Wegener granulomatosis. Medicine. 2006;85(1):53–65. 10.1097/01.md.0000200166.90373.41
85 Pawlitzki M, Perosa V, Korsen M, Mawrin C, Bartels C, Huchtemann T. Aggressive spinal cord involvement in granulomatosis with polyangiitis. Int J Rheum Dis. 2019;22(4): 756–8. 10.1111/1756-185X.13561
86 Gasparinho R, Fernandes N, Martins M, Santos N, Ferreira LP, Alho A. Psychosis as the first manifestation of granulomatosis with polyangiitis–A case report. Psychiatr Danub. 2022;34(2):315–7. 10.24869/psyd.2022.315
87 Verma S, Joshi R, Shah R. Acne fulminans in a young man with granulomatosis with polyangiitis (Wegener’s granulomatosis): A chance association or marker of serious systemic disease? Indian J Dermatol Venereol Leprol. 2020;86(6): 669–73. 10.4103/ijdvl.IJDVL_155_18
88 Gajic-Veljic M, Nikolic M, Peco-Antic A, Bogdanovic R, Andrejevic S, Bonaci-Nikolic B. Granulomatosis with polyangiitis (Wegener’s granulomatosis) in children: Report of three cases with cutaneous manifestations and literature review. Pediatr Dermatol. 2013;30(4):e37–42. 10.1111/pde.12034
89 Fotis L, Prountzos S, Giannouli G, Papaevangelou V. Facial necrotic ulcerative lesions in an adolescent female with granulomatosis with polyangiitis (GPA). Clin Rheumatol. 2020;39(11):3519–20. 10.1007/s10067-020-05264-4
90 Jamali Moghadam SR, Salehi MR, Mojtahedi SY, Fadaei N, Dadras O, SeyedAlinaghi S, et al. Granulomatosis with polyangiitis (GPA) in a 15-year-old girl with facial acne-like ulcers: A case report. Infect Disord Drug Targets. 2020;20(6):932–6. 10.2174/1871526519666191115105036
91 Sekeres J, Bruzzese JM, John RM. An adolescent male with a nonhealing leg ulcer: A case of granulomatosis with polyangiitis. Nurse Pract. 2018;43(11):18–23. 10.1097/01.NPR.0000546446.86603.2f
92 Moen BH, Nystad TW, Barrett TM, Sandvik LF. A boy in his teens with large ulcerations of the head and neck. Tidsskr Nor Laegeforen. 2019;139(7).
93 Arfaoui H, Elkihal H, Jabri H, Elkhattabi W, Afif H. Adolescent with severe granulomatosis with polyangiitis: a case report. Pan Afr Med J. 2021;38:285. 10.11604/pamj.2021.38.285.26893
94 Bui T, Chandrakasan S, Poulik J, Fathalla BM. Granulomatosis with polyangiitis presenting as Henoch-Schönlein purpura in children. J Clin Rheumatol. 2013;19(4):199–202. 10.1097/RHU.0b013e318293aff5
95 Sarlon G, Durant C, Grandgeorge Y, Bernit E, Veit V, Hamidou M, et al. Cardiac involvement in Wegener’s granulomatosis: Report of four cases and review of the literature. Rev Med Interne. 2010;31(2):135–9. 10.1016/j.revmed.2009.06.007
96 Grant SC, Levy RD, Venning MC, Ward C, Brooks NH. Wegener’s granulomatosis and the heart. Heart. 1994;71(1):82–6. 10.1136/hrt.71.1.82
97 Hirata M, Miyazawa H, Morino J, Kaneko S, Minato S, Katsunori Y, et al. A case report of PR-3-ANCA-positive glomerulonephritis with histological features of GPA associated with infectious endocarditis. Medicine. 2021;100(32):e26905. 10.1097/MD.0000000000026905
98 Merkel PA, Lo GH, Holbrook JT, Tibbs AK, Allen NB, Davis JC, et al. Brief communication: high incidence of venous thrombotic events among patients with Wegener granulomatosis: The Wegener’s clinical occurrence of thrombosis (WeCLOT) study. Ann Intern Med. 2005;142(8):620–6. 10.7326/0003-4819-142-8-200505030-00011
99 Allenbach Y, Seror R, Pagnoux C, Teixeira L, Guilpain P, Guillevin L, et al. High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: A systematic retrospective study on 1130 patients. Ann Rheum Dis. 2009;68(4):564–7. 10.1136/ard.2008.099051
100 Isaacs B, Gapud EJ, Antiochos B, Seo P, Geetha D. Venous thrombotic events in ANCA-associated vasculitis: Incidence and risk factors. Kidney360. 2020;1(4):258–62. 10.34067/KID.0000572019
101 Pan L, Yan JH, Gao FQ, Li H, Han SS, Cao GH, et al. Case report of a 28-year-old man with aortic dissection and pulmonary shadow due to granulomatosis with polyangiitis. BMC Pulm Med. 2019;19(1):122. 10.1186/s12890-019-0884-9
102 Rehani C, Nelson JS. Coronary artery aneurysms as a feature of granulomatosis with polyangiitis. Pediatrics. 2021;147(1):e20200932. 10.1542/peds.2020-0932
103 Deniz K, Ozşeker HS, Balas S, Akpýnar E, Sökmensüer C. Intestinal involvement in Wegener’s granulomatosis. J Gastrointestin Liver Dis. 2007;16(3):329–31.
104 Yildirim AC, Koçak E, Yildiz P, Yildiz M, Karakayali AŞ, Kaptanoglu B, et al. Multiple intestinal perforation in a patient with Wegener’s granulomatosis: a case report and review of the literature. Gastroenterol Clin Biol. 2010 Dec;34(12):712–5. 10.1016/j.gcb.2010.08.009
105 Yasin S, Mehmood K. Recurrent gastrointestinal bleeding due to jejunal artery vasculitis as debut presentation of granulomatosis with polyangiitis. BMJ Case Rep. 2021;14(1):e237876. 10.1136/bcr-2020-237876
106 Gu X, Ma L, Shi M, Chi S, Huang L. A case of Wegener’s granulomatosis presenting with gastrointestinal bleeding. Gastroenterol Nurs. 2021;44(6):455–7. 10.1097/SGA.0000000000000567
107 Rees DO, Gunavardhan A, Glover DA. Granulomatosis with polyangiitis: an unusual cause of acute liver injury. BMJ Case Rep. 2018;2018:bcr-2017-222464. 10.1136/bcr-2017-222464
108 Tyagi S, Bajpai G. Acute pancreatitis: An atypical presentation of granulomatosis with polyangiitis. Rheumatology. 2021; 60(3):e83–4. 10.1093/rheumatology/keaa513
109 Garbe N, Keyßer G, Schäfer C, Garbe J. Pancreatitis as the leading manifestation of granulomatosis with polyangiitis: Case report and review of the literature. Pancreas. 2021;50(10):e85–8. 10.1097/MPA.0000000000001944
110 Vega-Beyhart A, Medina-Rangel IR, Hinojosa-Azaola A, Fernández-Barrio M, Vargas-Castro AS, García-Inciarte L, et al. Pituitary dysfunction in granulomatosis with polyangiitis. Clin Rheumatol. 2020;39(2):595–606. 10.1007/s10067-019-04735-7
111 Gu Y, Sun X, Peng M, Zhang T, Shi J, Mao J. Pituitary involvement in patients with granulomatosis with polyangiitis: Case series and literature review. Rheumatol Int. 2019;39(8):1467–76. 10.1007/s00296-019-04338-0
112 Kapoor E, Cartin-Ceba R, Specks U, Leavitt J, Erickson B, Erickson D. Pituitary dysfunction in granulomatosis with polyangiitis: The Mayo Clinic experience. J Clin Endocrinol Metab. 2014;99(11):3988–94. 10.1210/jc.2014-1962
113 Piper K, Beldick SR, Karsy M, Allawh T, Shirodkar M, Miller J, et al. Granulomatosis with polyangiitis masquerading as pituitary adenoma with apoplexy. Mod Rheumatol Case Rep. 2021;5(2):342–6. 10.1080/24725625.2021.1909222
114 Trives-Folguera L, Isenberg D. A curious case of granulomatosis with polyangiitis: Prostatic and skin involvement. Rheumatol Adv Pract. 2022;6(2):rkac033. 10.1093/rap/rkac033
115 Ahmadnia H, Hasanzadeh Haddad A, Darabi Mahboub MR, Akhavan Rezayat AR. A nonspecific penile ulcer leading to the diagnosis of Wegener’s granulomatosis. Urol J. 2020;17(2):210–2.
116 Ahmed HMA, Elfishawi MM, Hagiga A, Ahmed IMA, Chen YL. Urethral involvement in granulomatosis with polyangiitis: A case-based review. Rheumatol Int. 2019;39(7):1279–84. 10.1007/s00296-019-04331-7
117 Jarrot PA, Pelletier ML, Brun M, Penicaud M, Mazodier K, Benyamine A, et al. Bilateral breast ulcers: Granulomatosis with polyangiitis. Am J Med. 2019;132(2):179–81. 10.1016/j.amjmed.2018.09.008
118 Cagan M, Fadiloglu E, Unal C, Beksac MS. Granulomatosis with polyangiitis and pregnancy: Anti-neutrophil cytoplasmic antibody, placental inflammation, chorangiosis and pre-eclampsia. J Obstet Gynaecol Res. 2020;46(9):1907–10. 10.1111/jog.14356
119 Folci M, Ramponi G, Shiffer D, Zumbo A, Agosti M, Brunetta E. ANCA-associated vasculitides and hematologic malignancies: Lessons from the past and future perspectives. J Immunol Res. 2019;2019:1732175. 10.1155/2019/1732175
120 Mohammed T, Thomas S, Sepúlveda-Ramos M, Premkumar P, Glomski K, Dailey M, et al. Granulomatosis with polyangiitis associated with hemophagocytic lymphohistiocytosis. J Clin Rheumatol. 2021;27(8 Suppl):S827–8. 10.1097/RHU.0000000000001432
121 Rezac J, Honsova E, Masek M, Rysava R, Neprasova M, Jancova E, et al. Granulomatosis with polyangiitis mimicking cancer: A diagnostic dilemma. J Nephrol. 2022;35(2):675–8. 10.1007/s40620-021-01128-5
122 Gendelman O, Kuntzman Y, Shovman O, Langevitz P, Tsur AM, Erez D, et al. Tumor-like lesions in patients with granulomatosis with polyangiitis: A case series. Isr Med Assoc J. 2021;23(6):350–2.
123 Tian Y, Zhang Y, Wen B, Li C, He Y. 18F-FDG PET/CT findings of granulomatosis with polyangiitis mimicking malignant lymphoma. J Clin Rheumatol. 2021;27(5):e194–5. 10.1097/RHU.0000000000001363
124 Piccirilli G, Chiereghin A, Maritati M, Turello G, Felici S, La Corte R, et al. Multidrug-resistant cytomegalovirus infection in a patient with granulomatosis with polyangiitis during immunosuppressive treatment. Antivir Ther. 2020;25(2):111–4. 10.3851/IMP3352
125 Soriano A, Smerieri N, Bonilauri S, De Marco L, Cavazza A, Salvarani C. Colonic perforation due to severe cytomegalovirus disease in granulomatosis with polyangiitis after immunosuppression. Clin Rheumatol. 2018;37(5):1427–32. 10.1007/s10067-017-3945-6
126 Morishita M, Sada KE, Matsumoto Y, Hayashi K, Asano Y, Hiramatsu Asano S, et al. Risk factors for cytomegalovirus infection in patients with antineutrophil cytoplasmic antibody-associated vasculitis. PLoS One. 2019;14(7):e0218705. 10.1371/journal.pone.0218705
127 Reddy S, Tyagi M, Behera S, Pappuru RR. Cytomegalovirus retinitis in a patient of granulomatosis with polyangiitis on long-term immunosuppressants. BMJ Case Rep. 2021;14(2):e236632. 10.1136/bcr-2020-236632
128 Kariv R, Sidi Y, Gur H. Systemic vasculitis presenting as a tumorlike lesion. Four case reports and an analysis of 79 reported cases. Medicine. 2000;79(6):349–59. 10.1097/00005792-200011000-00001
129 Mukhtyar C, Flossmann O, Hellmich B, Bacon P, Cid M, Cohen-Tervaert JW, et al. Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: A systematic review by the European League Against Rheumatism systemic vasculitis task force. Ann Rheum Dis. 2008;67(7):1004–10. 10.1136/ard.2007.071936
130 Chaigne B, Guillevin L. Unsolved questions and concerns about treatment of anti-neutrophil cytoplasm antibody-associated vasculitides. Clin Exp Rheumatol. 2016;34(3 Suppl 97):S121–8.
131 Elefante E, Monti S, Bond M, Lepri G, Quartuccio L, Talarico R, et al. One year in review 2017: Systemic vasculitis. Clin Exp Rheumatol. 2017;35 Suppl 103(1):5–26.
132 Tan JA, Dehghan N, Chen W, Xie H, Esdaile JM, Avina-Zubieta JA. Mortality in ANCA-associated vasculitis: A meta-analysis of observational studies. Ann Rheum Dis. 2017;76(9):1566–74. 10.1136/annrheumdis-2016-210942
133 Nölle B, Specks U, Lüdemann J, Rohrbach MS, DeRemee RA, Gross WL. Anticytoplasmic autoantibodies: Their immunodiagnostic value in Wegener granulomatosis. Ann Intern Med. 1989;111(1):28–40. 10.7326/0003-4819-111-1-28
134 Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan SM, et al. Mechanisms of autoantibody-induced pathology. Front Immunol. 2017;8:603. 10.3389/fimmu.2017.00603
135 Damoiseaux J, Csernok E, Rasmussen N, Moosig F, van Paassen P, Baslund B, et al. Detection of antineutrophil cytoplasmic antibodies (ANCAs): A multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Ann Rheum Dis. 2017;76(4):647–53. 10.1136/annrheumdis-2016-209507
136 Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, et al. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005;143(9):621–31. 10.7326/0003-4819-143-9-200511010-00005
137 Walsh M, Flossmann O, Berden A, Westman K, Höglund P, Stegeman C, et al. Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2012;64(2):542–8. 10.1002/art.33361
138 Cornec D, Gall ECL, Fervenza FC, Specks U. ANCA-associated vasculitis—clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol. 2016;12(10):570–9. 10.1038/nrrheum.2016.123
139 Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis. 2022;81(3):315–20. 10.1002/art.41986
140 Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, et al. American College of Rheumatology/European Alliance of Associations for Rheumatology Classification Criteria for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis. 2022;81(3):309–14. 10.1002/art.41982
141 Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, et al. American College of Rheumatology/European Alliance of Associations for rheumatology classification criteria for microscopic polyangiitis. Arthritis Rheumatol. 2022;74(3):400–6. 10.1002/art.41983
142 Pyo JY, Lee LE, Park YB, Lee SW. Comparison of the 2022 ACR/EULAR classification criteria for antineutrophil cytoplasmic antibody-associated vasculitis with previous criteria. Yonsei Med J. 2023;64(1):11–7. 10.3349/ymj.2022.0435
143 Monach PA. Biomarkers in vasculitis. Curr Opin Rheumatol. 2014;26(1):24. 10.1097/BOR.0000000000000009
144 Kenison JE, Stevens NA, Quintana FJ. Therapeutic induction of antigen-specific immune tolerance. Nat Rev Immunol. 2024;24(5):338–57. 10.1038/s41577-023-00970-x
145 Lodka D, Zschummel M, Bunse M, Rousselle A, Sonnemann J, Kettritz R, et al. CD19-targeting CAR T cells protect from ANCA-induced acute kidney injury. Ann Rheum Dis. 2024;83(4):499–507. 10.1136/ard-2023-224875
146 Ueda N, Cahen M, Leonard J, Deleurme L, Dreano S, Sirac C, et al. Single-hit genome editing optimized for maturation in B cells redirects their specificity toward tumor antigens. Sci Rep. 2024;14(1):22432. 10.1038/s41598-024-74005-3
147 Longhurst HJ, Lindsay K, Petersen RS, Fijen LM, Gurugama P, Maag D, et al. CRISPR-Cas9 in vivo gene editing of KLKB1 for hereditary angioedema. N Engl J Med. 2024;390(5):432–41. 10.1056/NEJMoa2309149
148 Sadeghpour Heravi F. Gut microbiota and autoimmune diseases: Mechanisms, treatment, challenges, and future recommendations. Curr Clin Micro Rpt. 2024;11(1):18–33. 10.1007/s40588-023-00213-6
149 Manfredo Vieira S, Hiltensperger M, Kumar V, Zegarra-Ruiz D, Dehner C, Khan N, et al. Translocation of a gut pathobiont drives autoimmunity in mice and humans. Science. 2018;359(6380):1156–61. 10.1126/science.aar7201